T-cell-mediated inflammation does not contribute to the maintenance of airway dysfunction in mice

Journal of Applied Physiology

Volumn 97, Issue 6, 2004, Pages 2258-2265

  Leigh, Richard ^a   Southam, David S ^a   Ellis, Russ ^a   Wattie, Jennifer N ^a   Sehmi, Roma ^a   Wan, Yonghong ^a   Inman, Mark D ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Allergy; Bronchial hyperreactivity; Lung; Rodent; T lymphocytes

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CD8 ANTIGEN; METHACHOLINE; MONOCLONAL ANTIBODY; OVALBUMIN;

AIRWAY RESISTANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; EOSINOPHIL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IMAGE ANALYSIS; LUNG; LUNG LAVAGE; LYMPHOCYTE COUNT; MORPHOMETRICS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY TRACT INFLAMMATION; SPLEEN; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ALLERGENS; ANIMALS; ANTIBODIES, MONOCLONAL; BRONCHIAL HYPERREACTIVITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FEMALE; HYPERSENSITIVITY; MICE; MICE, INBRED BALB C; PNEUMONIA;

EID: 9244231169     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.00597.2004     Document Type: Article

References (56)

1. Borish LC, Nelson HS, Lanz MJ, Claussen L, Whitmore JB, Agosti JM, and Garrison L. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial. Am J Respir Crit Care Med 160: 1816-1823, 1999.
2. Boulet LP, Chakir J, Dube J, Laprise C, Boutet M, and Laviolette M. Airway inflammation and structural changes in airway hyper-responsiveness and asthma: an overview. Can Respir J 5: 16-21, 1998.
3. Boulet LP, Cowie RL, Negro RD, Brett W, Gold M, Marques A, Thorburn WS, Stepner NM, and Robson R. Comparison of once- with twice-daily dosing of fluticasone propionate in mild and moderate asthma. Can Respir J 7: 239-247, 2000.
4. Boulet LP, Laviolette M, Turcotte H, Cartier A, Dugas M, Malo JL, and Boutet M. Bronchial subepithelial fibrosis correlates with airway responsiveness to methacholine. Chest 112: 45-52, 1997.
5. Boulet LP, Turcotte H, Laviolette M, Naud F, Bernier MC, Martel S, and Chakir J. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma. Influence of inhaled corticosteroids. Am J Respir Crit Care Med 162: 1308-1313, 2000.
6. Brusasco V, Crimi E, Gianiorio P, Lantero S, and Rossi GA. Allergen-induced increase in airway responsiveness and inflammation in mild asthma. J Appl Physiol 69: 2209-2214, 1990.
7. Brusselle GG, Kips JC, Tavernier JH, van der Heyden JG, Cuvelier CA, Pauwels RA, and Bluethmann H. Attenuation of allergic airway inflammation in IL-4 deficient mice. Clin Exp Allergy 24: 73-80, 1994.
8. Busse W, Elias J, Sheppard D, and Banks-Schlegel S. Airway remodeling and repair. Am J Respir Crit Care Med 160: 1035-1042, 1999.
9. Busse WW and Lemanske RF Jr. Asthma. N Engl J Med 344: 350-362, 2001.
10. Carroll N, Elliot J, Morton A, and James A. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 147: 405-410, 1993.
11. Corrigan CJ and Kay AB. T-cells and eosinophils in the pathogenesis of asthma. Immunol Today 113: 501-507, 1992.
12. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, and Locksley RM. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 183: 109-117, 1996.
13. Corry DB, Grunig G, Hadeiba H, Kurup VP, Warnock ML, Sheppard D, Rennick DM, and Locksley RM. Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice. Mol Med 4: 344-355, 1998.
14. Davies DE, Wicks J, Powell RM, Puddicombe SM, and Holgate ST. Airway remodeling in asthma: new insights. J Allergy Clin Immunol 111: 215-225, 2003.
15. Djukanovic R, Wilson JW, Britten KM, Wilson SJ, Walls AF, Roche WR, Howarth PH, and Holgate ST. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am Rev Respir Dis 145: 669-674, 1992.
16. Elias JA, Zhu Z, Chupp G, and Homer RJ. Airway remodeling in asthma. J Clin Invest 104: 1001-1006, 1999.
17. Ellis R, Leigh R, Southam DS, O'Byrne PM, and Inman MD. Morphometric analysis of mouse airways following chronic allergen challenge. Lab Invest 83: 1285-1291, 2003.
18. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, and Young IG. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195-201, 1996.
19. Foster PS, Yang M, Herbert C, and Kumar RK. CD4(+) T-lymphocytes regulate airway remodeling and hyper-reactivity in a mouse model of chronic asthma. Lab Invest 82: 455-462, 2002.
20. Gavett SH, Chen X, Finkelman F, and Wills-Karp M. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am J Respir Cell Mol Biol 10: 587-593, 1994.
21. Gavett SH, O'Hearn DJ, Karp CL, Patel EA, Schofield BH, Finkelman FD, and Wills-Karp M. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol Lung Cell Mol Physiol 272: L253-L261, 1997.
22. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, and Corry DB. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282: 2261-2263, 1998.
23. Hamelmann E, Oshiba A, Schwarze J, Bradley K, Loader J, Larsen GL, and Gelfand EW. Allergen-specific IgE and IL-5 are essential for the development of airway hyperresponsiveness. Am J Respir Cell Mol Biol 16: 674-682, 1997.
24. Hamid Q. Airway remodeling in asthma. J Allergy Clin Immunol 111: 1420-1421, 2003.
25. Hegele RG, Hayashi S, Hogg JC, and Pare PD. Mechanisms of airway narrowing and hyperresponsiveness in viral respiratory tract infections. Am J Respir Crit Care Med 151: 1659-1664, 1995.
26. Hogaboam CM, Blease K, Mehrad B, Steinhauser ML, Standiford TJ, Kunkel SL, and Lukacs NW. Chronic airway hyperreactivity, goblet cell hyperplasia, and peribronchial fibrosis during allergic airway disease induced by Aspergillus fumigatus. Am J Pathol 156: 723-732, 2000.
27. Hogan SP, Matthaei KI, Young JM, Koskinen A, Young IG, and Foster PS. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J Immunol 161: 1501-1509, 1998.
28. Inman MD, Ellis R, Wattie J, Denburg JA, and O'Byrne PM. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 21: 473-479, 1999.
29. James AL, Pare PD, and Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 139: 242-246, 1989.
30. Jeffery PK, Godfrey RW, Adelroth E, Nelson F, Rogers A, and Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 145: 890-899, 1992.
31. Jeffery PK, Wardlaw AJ, Nelson FC, Collins JV, and Kay AB. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 140: 1745-1753, 1989.
32. Kon OM, Sihra BS, Compton CH, Leonard TB, Kay AB, and Barnes NC. Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet 352: 1109-1113, 1998.
33. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, and Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 148: 1220-1225, 1993.
34. Lambert RK, Wiggs BR, Kuwano K, Hogg JC, and Pare PD. Functional significance of increased airway smooth muscle in asthma and COPD. J Appl Physiol 74: 2771-2781, 1993.
35. Laprise C, Laviolette M, Boutet M, and Boulet LP. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J 14: 63-73, 1999.
36. Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, and Barnes PJ. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356: 2144-2148, 2000.
37. Leigh R, Ellis R, Wattie J, Southam DS, De Hoogh M, Gauldie J, O'Byrne PM, and Inman MD. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 27: 526-535, 2002.
38. Mattes J, Yang M, Mahalingam S, Kuehr J, Webb DC, Simson L, Hogan SP, Koskinen A, McKenzie AN, Dent LA, Rothenberg ME, Matthaei KI, Young IG, and Foster PS. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma. J Exp Med 195: 1433-1444, 2002.
39. O'Byrne PM and Inman MD. Airway hyperresponsiveness. Chest 123: 411S-416S, 2003.
40. Padrid PA, Mathur M, Li X, Herrmann K, Qin Y, Cattamanchi A, Weinstock J, Elliott D, Sperling AI, and Bluestone JA. CTLA41g inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma. Am J Respir Cell Mol Biol 18: 453-462, 1998.
41. Palmans E, Kips JC, and Pauwels RA. Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 161: 627-635, 2000.
42. Robinson DS, Bentley AM, Hartnell A, Kay AB, and Durham SR. Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness. Thorax 48: 26-32, 1993.
43. Roche WR, Beasley R, Williams JH, and Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1: 520-524, 1989.
44. Sont JK, Willems LN, Bel EH, van Krieken JH, Vandenbroucke JP, and Sterk PJ. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 159: 1043-1051, 1999.
45. Tanaka H, Masuda T, Tokuoka S, Komai M, Nagao K, Takahashi Y, and Nagai H. The effect of allergen-induced airway inflammation on airway remodeling in a murine model of allergic asthma. Inflamm Res 50: 616-624, 2001.
46. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, and Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 53: 849-856, 1998.
47. Trifilieff A, El Hashim A, and Bertrand C. Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am J Physiol Lung Cell Mol Physiol 279: L1120-L1128, 2000.
48. Venkayya R, Lam M, Willkom M, Grunig G, Corry DB, and Erle DJ. The Th2 lymphocyte products IL-4 and IL-13 rapidly induce airway hyperresponsiveness through direct effects on resident airway cells. Am J Respir Cell Mol Biol 26: 202-208, 2002.
49. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, and Bonsignore G. Airway remodeling in asthma. Chest 123: 417S-422S, 2003.
50. Volgyesi GA, Tremblay LN, Webster P, Zamel N, and Slutsky AS. A new ventilator for monitoring lung mechanics in small animals. J Appl Physiol 89: 413-421, 2000.
51. Wang L, McParland BE, and Pare PD. The functional consequences of structural changes in the airways: implications for airway hyperresponsiveness in asthma. Chest 123: 356S-362S, 2003.
52. Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, and Kay AB. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 137: 62-69, 1988.
53. Webb DC, McKenzie AN, Koskinen AM, Yang M, Mattes J, and Foster PS. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol 165: 108-113, 2000.
54. Wiggs BR, Bosken C, Pare PD, James A, and Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 145: 1251-1258, 1992.
55. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, and Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261, 1998.
56. Yoshida M, Leigh R, Matsumoto K, Wattie J, Ellis R, O'Byrne PM, and Inman MD. Effect of interferon-gamma on allergic airway responses in interferon-gamma-deficient mice. Am J Respir Crit Care Med 166: 451-456, 2002.